Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Depreciation and Depletion (2019 - 2025)

InspireMD (NSPR) has 10 years of Depreciation and Depletion data on record, last reported at $128000.0 in Q3 2025.

  • For Q3 2025, Depreciation and Depletion rose 82.86% year-over-year to $128000.0; the TTM value through Sep 2025 reached $408000.0, up 53.38%, while the annual FY2024 figure was $280000.0, 20.69% up from the prior year.
  • Depreciation and Depletion reached $128000.0 in Q3 2025 per NSPR's latest filing, up from $107000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $128000.0 in Q3 2025 and bottomed at $33000.0 in Q2 2021.
  • Average Depreciation and Depletion over 5 years is $64111.1, with a median of $58000.0 recorded in 2023.
  • Peak YoY movement for Depreciation and Depletion: dropped 19.61% in 2022, then surged 82.86% in 2025.
  • A 5-year view of Depreciation and Depletion shows it stood at $37000.0 in 2021, then skyrocketed by 45.95% to $54000.0 in 2022, then increased by 12.96% to $61000.0 in 2023, then increased by 22.95% to $75000.0 in 2024, then surged by 70.67% to $128000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Depreciation and Depletion were $128000.0 in Q3 2025, $107000.0 in Q2 2025, and $98000.0 in Q1 2025.